Associate Professor
Ferhat Ferhatoğlu, M.D.
Medical Oncology
Yeditepe University Koşuyolu Hospital
Medical Oncology
Personal Information
Birth Place & YearGaziantep - 1987
Emailferhat.ferhatoglu@yeditepe.edu.tr
Education
Medical SchoolMersin University Faculty of Medicine - 2010
Specializationİstanbul University Institute of Oncology - 2017
Side Branch SpecializationMedical Oncology
Associate ProfessorshipBasaksehir Cam and Sakura City Hospital - 2023
Languages
English
Publications & Recognition
10
International Papers
14
National Papers
1
Turkish Publications
247
Citations
Fields of Expertise
- Personalized Treatments
- NGS and Molecular Oncology
- Prostate Cancer
- Kidney and Bladder Cancer
- Breast Cancer
- Lung Cancer
- Stomach and Colorectal Cancers
- Gynecological Cancers
- Malignant Melanoma and Sarcomas
Publications
37
Career Summary
- Muş State Hospital (Apr 2021 - Aug 2024)
- Basaksehir Cam and Sakura City Hospital, İstanbul (Aug 2021 - Mar 2023)
- Istanbul Aydın University Health Practice and Research Center (Sep 2023 - Apr 2025)
- Bahrain Oncology Center (Apr 2025 - Apr 2026)
Book Chapters
- Targeted Therapies in Oncology Through Clinical Studies: Hepatobiliary System Tumors
- Targeted Therapies in Oncology Through Clinical Studies: Kidney Tumors
- Turkey Clinics Pediatric Hematology and Oncology – Special Topics: Fanconi Anemia and Malignancies: Chemotherapy Modifications in Fanconi Anemia Patients Who Develop Cancer
- Current Approaches to Breast Cancer: Breast Cancer in Young Women Bıology And Treatment
- Local Treatment Approaches in Breast Cancer: Inflammatory Breast Cancer
Projects
- Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects with Gastrointestinal, Pancreatic, or Colorectal Cancer
(RECITE) - A Study of PF-05280014 [Trastuzumab-Pfizer] or Herceptin [Trastuzumab-EU] Plus Paclitaxel in HER2 Positive First-Line Metastatic Breast Cancer Treatment
(REFLECTIONS B327-02)
Memberships
- Turkish Medical Association (TTB)
- Turkish Society of Medical Oncology (TTOD)
- European Society of Medical Oncology (ESMO)
Certificates
- Experımental Anımal Use Certıfıcate (2015)
- Turkish Society of Internal Medicine Board Certificate (2017)
Good Clinical Practice Certificate (2018) - Gustavo Roussy Cancer Campus (Master Class, Breast - Lung – Prostate
Cancers), Paris, France (2018) - Immune checkpoint inhibitör (ICPI) Treatment (ID 640907) provided by CEGOG, Vienna, Austria (2019)
- Traın The Traıners Certıfıcate (2020)
- Turkish Society of Medical Oncology Board Certificate (2021)
